Skip to content

A Clinical Study to Evaluate The Effect Of Virechana (Purgation Therapy)Followed by Aragvadhamruthadi kashaya(Herbal decoction)and Aragvadhapatra Lepa (Poultice) in The Management Of Kitibhakushta (Skin Disease) vis-à-vis Psoriasis

A Clinical Study to Evaluate The Effect Of Virechana Followed by Aragvadhamruthadi kashaya and Aragvadhapatra Lepa in The Management Of Kitibhakushta vis-à-vis Psoriasis - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036123
Enrollment
30
Registered
2021-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Sponsors

Dr Rachana P Badaji
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects presenting with Lakshanas of Kitibhakusta Subjects presenting with signs & symptoms of Psoriasis Post covid and Non covid patients Subjects fit for Snehapana Subjects fit for Virechana karma

Exclusion criteria

Exclusion criteria: Psoriasis associated with Major systemic disorders that interfere with the course of treatment. Persons who are not indicated for Snehapana and Virechana.

Design outcomes

Primary

MeasureTime frame
Virechana karma followed by Orally Aragvadamruthadi kashaya and Aragvadapatra Lepa external application is Effective in management of KitibhakustaTimepoint: one and half year

Secondary

MeasureTime frame
NilTimepoint: Not Applicable

Countries

India

Contacts

Public ContactDr C V Rajashekhar

Sri Kalabyraveswara Swamy Ayurvedic Medical College Hospital And Research Centre Banglore

drrajhere@yahoo.co.in8867212844

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026